LX22NPO5102) - Funded by the European Union - Next Generation EU, Programme EXCELES
3.4 Adverse events Three subjects experienced intermittent diarrhea, bloating and nausea before the initiation of semaglutide treatment (timepoint 1), but the symptoms were not severe enough to warrant discontinuation of metformin therapy
Malabsorptive procedures influence intestinal peptides, hormones, and the entero-encephalic endocrine axis, with RYGB employing both mechanisms but primarily relying on malabsorption for weight loss [1]
It is important to note that currently only two GLP-1 RA agents have the indication for management of obesity: Wegovy (semaglutide) and Saxenda (liraglutide)
It is not known if Ozempic will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
How it works: Nutrients go right into your blood, bypassing your digestive system